Intravenous parecoxib sodium foracute pain after orthopedic knee surgery.

G. Lynn Rasmussen, Karen Steckner, Charles Hogue, Sarah Torri, Richard C. Hubbard

Research output: Contribution to journalArticle

Abstract

Our objective in a randomized, multicenter, double-blind, parallel-group, placebo- and active-controlled study was to evaluate and compare the analgesic effectiveness of single intravenous (IV) doses of parecoxib sodium 20 and 40 mg, morphine 4 mg, and ketorolac 30 mg in the postsurgical orthopedic pain model. After undergoing unilateral total knee replacement surgery, 208 healthy adult patients were randomized to receive placebo or a study drug within 6 hours of discontinuation of patient-controlled analgesia on postoperative day 1. Onset of analgesia was similarly rapid with IV parecoxib sodium 40 mg, morphine, and ketorolac. Level and duration of analgesia were significantly superior with parecoxib sodium than with morphine and were similar for parecoxib sodium and ketorolac. Parecoxib sodium was safe and well tolerated. In conclusion, IV parecoxib sodium 40 mg is as effective as ketorolac 30 mg and is more effective than morphine 4 mg and therefore has potential widespread utility in acute postoperative pain management.

Original languageEnglish (US)
Pages (from-to)336-343
Number of pages8
JournalAmerican journal of orthopedics (Belle Mead, N.J.)
Volume31
Issue number6
StatePublished - Jun 2002
Externally publishedYes

Fingerprint

Ketorolac
Orthopedics
Knee
Pain
Morphine
Analgesia
Placebos
Patient-Controlled Analgesia
Knee Replacement Arthroplasties
Acute Pain
Pain Management
Postoperative Pain
Analgesics
parecoxib
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Surgery

Cite this

Rasmussen, G. L., Steckner, K., Hogue, C., Torri, S., & Hubbard, R. C. (2002). Intravenous parecoxib sodium foracute pain after orthopedic knee surgery. American journal of orthopedics (Belle Mead, N.J.), 31(6), 336-343.

Intravenous parecoxib sodium foracute pain after orthopedic knee surgery. / Rasmussen, G. Lynn; Steckner, Karen; Hogue, Charles; Torri, Sarah; Hubbard, Richard C.

In: American journal of orthopedics (Belle Mead, N.J.), Vol. 31, No. 6, 06.2002, p. 336-343.

Research output: Contribution to journalArticle

Rasmussen, GL, Steckner, K, Hogue, C, Torri, S & Hubbard, RC 2002, 'Intravenous parecoxib sodium foracute pain after orthopedic knee surgery.', American journal of orthopedics (Belle Mead, N.J.), vol. 31, no. 6, pp. 336-343.
Rasmussen GL, Steckner K, Hogue C, Torri S, Hubbard RC. Intravenous parecoxib sodium foracute pain after orthopedic knee surgery. American journal of orthopedics (Belle Mead, N.J.). 2002 Jun;31(6):336-343.
Rasmussen, G. Lynn ; Steckner, Karen ; Hogue, Charles ; Torri, Sarah ; Hubbard, Richard C. / Intravenous parecoxib sodium foracute pain after orthopedic knee surgery. In: American journal of orthopedics (Belle Mead, N.J.). 2002 ; Vol. 31, No. 6. pp. 336-343.
@article{908346f751f34e77a538b210ac451d85,
title = "Intravenous parecoxib sodium foracute pain after orthopedic knee surgery.",
abstract = "Our objective in a randomized, multicenter, double-blind, parallel-group, placebo- and active-controlled study was to evaluate and compare the analgesic effectiveness of single intravenous (IV) doses of parecoxib sodium 20 and 40 mg, morphine 4 mg, and ketorolac 30 mg in the postsurgical orthopedic pain model. After undergoing unilateral total knee replacement surgery, 208 healthy adult patients were randomized to receive placebo or a study drug within 6 hours of discontinuation of patient-controlled analgesia on postoperative day 1. Onset of analgesia was similarly rapid with IV parecoxib sodium 40 mg, morphine, and ketorolac. Level and duration of analgesia were significantly superior with parecoxib sodium than with morphine and were similar for parecoxib sodium and ketorolac. Parecoxib sodium was safe and well tolerated. In conclusion, IV parecoxib sodium 40 mg is as effective as ketorolac 30 mg and is more effective than morphine 4 mg and therefore has potential widespread utility in acute postoperative pain management.",
author = "Rasmussen, {G. Lynn} and Karen Steckner and Charles Hogue and Sarah Torri and Hubbard, {Richard C.}",
year = "2002",
month = "6",
language = "English (US)",
volume = "31",
pages = "336--343",
journal = "American Journal of Orthopedics",
issn = "1078-4519",
publisher = "Quadrant Healthcom Inc.",
number = "6",

}

TY - JOUR

T1 - Intravenous parecoxib sodium foracute pain after orthopedic knee surgery.

AU - Rasmussen, G. Lynn

AU - Steckner, Karen

AU - Hogue, Charles

AU - Torri, Sarah

AU - Hubbard, Richard C.

PY - 2002/6

Y1 - 2002/6

N2 - Our objective in a randomized, multicenter, double-blind, parallel-group, placebo- and active-controlled study was to evaluate and compare the analgesic effectiveness of single intravenous (IV) doses of parecoxib sodium 20 and 40 mg, morphine 4 mg, and ketorolac 30 mg in the postsurgical orthopedic pain model. After undergoing unilateral total knee replacement surgery, 208 healthy adult patients were randomized to receive placebo or a study drug within 6 hours of discontinuation of patient-controlled analgesia on postoperative day 1. Onset of analgesia was similarly rapid with IV parecoxib sodium 40 mg, morphine, and ketorolac. Level and duration of analgesia were significantly superior with parecoxib sodium than with morphine and were similar for parecoxib sodium and ketorolac. Parecoxib sodium was safe and well tolerated. In conclusion, IV parecoxib sodium 40 mg is as effective as ketorolac 30 mg and is more effective than morphine 4 mg and therefore has potential widespread utility in acute postoperative pain management.

AB - Our objective in a randomized, multicenter, double-blind, parallel-group, placebo- and active-controlled study was to evaluate and compare the analgesic effectiveness of single intravenous (IV) doses of parecoxib sodium 20 and 40 mg, morphine 4 mg, and ketorolac 30 mg in the postsurgical orthopedic pain model. After undergoing unilateral total knee replacement surgery, 208 healthy adult patients were randomized to receive placebo or a study drug within 6 hours of discontinuation of patient-controlled analgesia on postoperative day 1. Onset of analgesia was similarly rapid with IV parecoxib sodium 40 mg, morphine, and ketorolac. Level and duration of analgesia were significantly superior with parecoxib sodium than with morphine and were similar for parecoxib sodium and ketorolac. Parecoxib sodium was safe and well tolerated. In conclusion, IV parecoxib sodium 40 mg is as effective as ketorolac 30 mg and is more effective than morphine 4 mg and therefore has potential widespread utility in acute postoperative pain management.

UR - http://www.scopus.com/inward/record.url?scp=0036599136&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036599136&partnerID=8YFLogxK

M3 - Article

VL - 31

SP - 336

EP - 343

JO - American Journal of Orthopedics

JF - American Journal of Orthopedics

SN - 1078-4519

IS - 6

ER -